Abstract |
In multiple sclerosis (MS), B cell-depleting therapy using monoclonal anti-CD20 Abs, including rituximab (RTX) and ocrelizumab, effectively reduces disease activity. Based on indirect evidence, it is generally believed that elimination of the Ag-presenting capabilities and Ag nonspecific immune functions of B cells underlie the therapeutic efficacy. However, a small subset of T lymphocytes (T cells) was shown to also express CD20, but controversy prevails surrounding the true existence of this T cell subpopulation. Using single-cell imaging flow cytometry and expression profiling of sorted lymphocyte subsets, we unequivocally demonstrate the existence of CD3(+)CD20(dim) T cells. We show that in MS patients, increased levels of CD3(+)CD20(dim) T cells are effectively depleted by RTX. The pathological relevance of this T cell subset in MS remains to be determined. However, given their potential proinflammatory functionality, depletion of CD20-expressing T cells may also contribute to the therapeutic effect of RTX and other mAbs targeting CD20.
|
Authors | Arumugam Palanichamy, Sarah Jahn, Dorothee Nickles, Mia Derstine, Aya Abounasr, Stephen L Hauser, Sergio E Baranzini, David Leppert, H-Christian von Büdingen |
Journal | Journal of immunology (Baltimore, Md. : 1950)
(J Immunol)
Vol. 193
Issue 2
Pg. 580-586
(Jul 15 2014)
ISSN: 1550-6606 [Electronic] United States |
PMID | 24928997
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2014 by The American Association of Immunologists, Inc. |
Chemical References |
- Antibodies, Monoclonal, Murine-Derived
- Antigens, CD19
- Antigens, CD20
- CD3 Complex
- Rituximab
|
Topics |
- Adult
- Aged
- Antibodies, Monoclonal, Murine-Derived
(therapeutic use)
- Antigens, CD19
(genetics, immunology, metabolism)
- Antigens, CD20
(genetics, immunology, metabolism)
- B-Lymphocytes
(immunology, metabolism)
- CD3 Complex
(genetics, immunology, metabolism)
- Female
- Flow Cytometry
- Humans
- Immunophenotyping
- Lymphocyte Depletion
- Male
- Middle Aged
- Multiple Sclerosis
(blood, drug therapy, immunology)
- Oligonucleotide Array Sequence Analysis
- Rituximab
- T-Lymphocyte Subsets
(immunology, metabolism)
- Transcriptome
(genetics, immunology)
- Young Adult
|